Drug Discovery - Medicine.net

Drug Discovery

Sub Categories on Drug Discovery

{{items.name}}

Latest Articles

Scientists identify lncRNA as potential biomarker and therapeutic target for hepatocellular carcinoma

Scientists identify lncRNA as potential biomarker and therapeutic target for hepatocellular carcinoma

Updated on: April 20,2025

Scientists identify lncRNA as potential biomarker and therapeutic target for hepatocellular carcinoma

Scientists identify lncRNA as potential biomarker and therapeutic target for hepatocellular carcinoma

Updated on:April 20,2025

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

Updated on: March 28,2025

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome

Updated on:March 28,2025

Florida leukemia rates rising rapidly as population ages

Florida leukemia rates rising rapidly as population ages

Updated on: April 20,2025

Florida leukemia rates rising rapidly as population ages

Florida leukemia rates rising rapidly as population ages

Updated on:April 20,2025

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Updated on: March 28,2025

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Global study finds new medication for sinus thrombosis is just as safe but more patient-friendly

Updated on:March 28,2025

Scientists reprogram cancer-protecting regulatory T cells to fight tumors

Scientists reprogram cancer-protecting regulatory T cells to fight tumors

Updated on: October 07,2025

Scientists reprogram cancer-protecting regulatory T cells to fight tumors

Scientists reprogram cancer-protecting regulatory T cells to fight tumors

Updated on:October 07,2025

Medication-induced sterol disruption: A silent threat to brain development and public health

Medication-induced sterol disruption: A silent threat to brain development and public health

Updated on: May 16,2025

Medication-induced sterol disruption: A silent threat to brain development and public health

Medication-induced sterol disruption: A silent threat to brain development and public health

Updated on:May 16,2025

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Updated on: April 20,2025

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Updated on:April 20,2025

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on: September 30,2025

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on:September 30,2025

Colon cancer considered cured after six years when relapse risk falls below 0.5%

Colon cancer considered cured after six years when relapse risk falls below 0.5%

Updated on: November 04,2025

Colon cancer considered cured after six years when relapse risk falls below 0.5%

Colon cancer considered cured after six years when relapse risk falls below 0.5%

Updated on:November 04,2025

Long-term analysis finds disease risk, not remission status, determines transplant outcomes in acute myeloid leukemia

Long-term analysis finds disease risk, not remission status, determines transplant outcomes in acute myeloid leukemia

Updated on: November 07,2025

Long-term analysis finds disease risk, not remission status, determines transplant outcomes in acute myeloid leukemia

Long-term analysis finds disease risk, not remission status, determines transplant outcomes in acute myeloid leukemia

Updated on:November 07,2025

Categories

Allergy&Clinical immunology

Anesthesiology & Pain

Cardiovascular Diseases

Diabetes & Endocrinology

Emergency Medicine & Critical Care

Family Medicine

Gastroenterology

General Surgery

Hematology&Oncology

Infectious Diseases

Nephrology & Urology

Orthopedics & Sports medicine

Plastic Surgery

Psychiatry & Mental Health

Public Health & Prevention